AIVITA Biomedical

About:

AIVITA Biomedical is is a medicine company develops commercial and clinical stage programs utilizing curative and regenerative medicines.

Website: http://aivitabiomedical.com

Top Investors: California Institute for Regenerative Medicine, California Technology Ventures, Big Sky Partners, SFC Co, Matthew Katz

Description:

AIVITA Biomedical is is a medicine company, develops commercial and clinical-stage programs utilizing curative and regenerative medicines. AIVITA Biomedical is a privately held company engaged in the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. AIVITA Biomedical utilizes its expertise in stem cell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its products and therapeutic pipeline.

Total Funding Amount:

$62.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Irvine, California, United States

Founded Date:

2016-01-01

Founders:

Hans Keirstead

Number of Employees:

11-50

Last Funding Date:

2022-08-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai